DIAmond Sessions
Conversations on Today’s Priorities!
Experience innovation through collaboration and gain global stakeholder perspective with thought-provoking discussion on life sciences issues, worldwide. Each session below will be deconstructed by acclaimed panelists and feature open conversations on controversial topics.
DIAmond Sessions represent rare opportunities for deeper connection with regulatory leadership through insightful dialogue. Join us in Chicago, IL to help forge cohesive pathways and processes toward the interconnected future of global health.
-
FDA Town Hall
Session Chair:
Courtney Granville, PhD, MPH, Global Associate Director, Research and Scientific Programs, DIA
-
EMA-FDA Question Time
Session Chair:
Sabine Haubenreisser, PhD, MSc, , Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency, Netherlands
Katherine Tyner, PhD, FDA Liaison to the EMA, Office of Global Policy and Strategy, OC, FDA
-
Preparing for the Future of Research and Development:10-Years of Multistakeholder Innovation, Collaboration, and Transformation
Session Chair:
Ania Mitan, Senior Vice President & Managing Director, DIA EMEA, India and Singapore
-
Leveraging Real-World Evidence to Address Diversity Gaps in Randomized Clinical Trials: Regulatory, Clinical, and Other Considerations
Session Chairs:
Nancy A. Dreyer, PhD, MPH, FISPE,Chief Scientific Officer & SVP, IQVIA